Skip to main content

Mª Jesus Melia Grimal

Institutions of which they are part

Research technician
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Mª Jesus Melia Grimal

Institutions of which they are part

Research technician
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Projects

Abordaje genético-molecular de enfermedades mitocondriales del sistema OXPHOS: identificación de factores condicionantes del fenotipo.

IP: Elena García Arumí
Collaborators: Albert Blanco Grau, Mª Jesus Melia Grimal, Paula Fernández Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 212052.5
Reference: PI15/01428
Duration: 01/01/2016 - 30/06/2019

Patologia Neuromuscular i Mitocondrial (GRC)

IP: Ramon Martí Seves
Collaborators: Antonio Luis Andreu Périz, Elena García Arumí, Yolanda Cámara Navarro, Albert Blanco Grau, Mª Jesus Melia Grimal, Tomàs Pinós Figueras, Raquel Cabrera Perez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 24000
Reference: 2014 SGR 842
Duration: 01/01/2014 - 31/12/2016

Determinantes reguladores de la expresión fenotípica en la enfermedad de McArdle: desarrollo de modelos experimentales.

IP: Tomàs Pinós Figueras
Collaborators: Mª Jesus Melia Grimal
Funding agency: Instituto de Salud Carlos III
Funding: 282716.5
Reference: PI10/00036
Duration: 01/01/2011 - 31/12/2013

Automatización de métodos de diagnóstico molecular de enfermedades mitocondriales. Parte 2, Hospital Vall d'Hebron: Validación del Mitochip (V2.0) de Affymetrix para el Screening de mutaciones en el DNA mitocondrial.

IP: Antonio Luis Andreu Périz
Collaborators: Elena García Arumí, Mª Jesus Melia Grimal, Ramon Martí Seves
Funding agency: Instituto de Salud Carlos III
Funding: 82885
Reference: PI08/90355
Duration: 01/01/2009 - 31/12/2010

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

Related professionals

Marc Simo Perdigo

Marc Simo Perdigo

Molecular Imaging and Therapy
Read more
Richard Miguel Lomas Albuja

Richard Miguel Lomas Albuja

Ethics Committees Support Unit (USCE)
External Strategy Directorate
Read more
Joaquim Sola  Santesmases

Joaquim Sola Santesmases

General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more
Katerina Papadakis

Katerina Papadakis

Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.